Shares of our common stock trade on the Nasdaq Capital Market under the symbol “LJPC.” Our website address is www.ljpc.com. Information contained on or ...
People also ask
What happened to LJPC stock?
What happened to La Jolla Pharmaceuticals?
What is the stock price of LJPC?
Jul 11, 2022 · ... ljpc.com. Source: Innoviva, Inc. Investor Relations · Press Releases · Events & Presentations · Corporate Presentation; Corporate Governance.
The company engages in developing LJPC-501, an angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome; and ...
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
... ljpc.com in the Corporate Governance section under “Investor Relations.” We intend to disclose future amendments to certain provisions of the Code of ...
Jul 11, 2022 · La Jolla Pharmaceutical will become a subsidiary of Innoviva, and La Jolla's common stock shares will no longer be listed on any public market.
Missing: relations | Show results with:relations
Aug 22, 2022 · ... Investor Relations. Investor Overview Press Releases ... La Jolla Pharmaceutical Company (Nasdaq: LJPC) ... Investor Relations · Press Releases ...
What You Need To Know About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) Investor Composition ... The big shareholder groups in La Jolla Pharmaceutical Company ...
La Jolla Pharmaceutical Company (LJPC) ... US:NASDAQ Investor Relations: lajollapharmaceutical.com/investor-relations ... LJPC), a leader in the discovery, ...
Senior Director of Investor Relations & Human Resources. Luke SeikkulaSenior Vice President of Pharmaceutical Operations. Lakhmir ChawlaConsultant, US$707.29k.